Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
The Journal of Urology
|
August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy
Alejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
BJU International
|
February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study
William C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Udit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
Daniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2025
Future directions in the evaluation and management of newly diagnosed metastatic cancer
Eric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
JCO Precision Oncology
|
January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate
William A Hall, Nick Fishbane, Yang Liu, et al.
European Urology Oncology
|
February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
The Journal of Urology
|
August 29, 2018
International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy
Alejandro Berlin, Fabio Y Moraes, Noelia Sanmamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C Jackson, Holly E Hartman, Robert T Dess, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
BJU International
|
February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study
William C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Udit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
Daniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2025
Future directions in the evaluation and management of newly diagnosed metastatic cancer
Eric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
JCO Precision Oncology
|
January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate
William A Hall, Nick Fishbane, Yang Liu, et al.
European Urology Oncology
|
February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Page
of 10